Skip to main content

Aristotle Capital Boston, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1633911 BOSTON, MA

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,497,928
-$1,156,871 QoQ
Shares Held
203,094
-13.4% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 78.14361822604312.ToString("F0")% Shared 0.ToString("F0")% None 21.856381773956887.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Aristotle Capital Boston, LLC holds $29,799,437 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (35.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 SUPN
Supernus Pharmaceuticals, Inc.
This page
203,094 $10,497,928

All Filings in SUPN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,497,928 203,094
2025-12-31 $11,654,799 234,503
2025-09-30 $14,588,996 305,273
2025-06-30 $25,480,610 808,395
2025-03-31 $28,580,532 872,688
2024-12-31 $38,903,386 1,075,868
2024-09-30 $37,235,966 1,194,226
2024-06-30 $32,184,690 1,203,166
2024-03-31 $38,880,147 1,139,846
2023-12-31 $33,565,422 1,159,828
2023-09-30 $32,752,636 1,187,981
2023-06-30 $34,928,126 1,161,947
2023-03-31 $41,851,048 1,155,149
2022-12-31 $40,195,845 1,126,881
2022-09-30 $39,183,169 1,157,553
2022-06-30 $36,663,040 1,267,740
2022-03-31 $40,660,725 1,258,067
2021-12-31 $37,496,027 1,285,872
2021-09-30 $35,153,967 1,318,109
2021-06-30 $32,688,295 1,061,653
2021-03-31 $25,480,810 973,293
2020-12-31 $25,704,110 1,021,626
2020-09-30 $22,349,899 1,072,452
2020-06-30 $24,411,152 1,027,838
2020-03-31 $13,324,095 740,639